Can GLP-1 Medications Improve Fertility?

    By Trimi Medical Team11 min read

    The "Ozempic baby" phenomenon is real: many patients on GLP-1 medications have conceived unexpectedly after years of infertility. Weight loss improves fertility through hormonal normalization, improved ovulation, and better reproductive outcomes. However, GLP-1 medications themselves must be stopped before pregnancy due to unknown fetal effects.

    Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are contraindicated during pregnancy. If you are planning pregnancy, discuss timing of medication discontinuation with your OB-GYN and prescribing provider. Use reliable contraception while on GLP-1 if pregnancy is not desired.

    How Weight Loss Improves Fertility

    In Women

    • Restored ovulation: Excess weight disrupts the hypothalamic-pituitary-ovarian axis. Losing 5-10% of body weight can restore regular ovulation in anovulatory women.
    • PCOS improvement: Weight loss reduces androgen levels, improves insulin resistance, and restores menstrual regularity in PCOS patients
    • Improved egg quality: Better insulin sensitivity and reduced inflammation improve oocyte quality
    • Better IVF outcomes: Lower BMI is associated with higher IVF success rates
    • Reduced miscarriage risk: Obesity increases miscarriage risk; weight loss reduces it

    In Men

    • Improved testosterone: Obesity suppresses testosterone through increased aromatase activity (converting testosterone to estrogen in fat tissue). Weight loss reverses this.
    • Better sperm parameters: Weight loss improves sperm count, motility, and morphology
    • Reduced scrotal temperature: Less abdominal fat reduces heat around the testes
    • Improved erectile function: Weight loss improves blood flow and hormonal balance

    The PCOS Connection

    PCOS affects 10-15% of women of reproductive age and is the leading cause of anovulatory infertility. GLP-1 weight loss is particularly impactful for PCOS because it addresses the core metabolic dysfunction:

    • Reduces insulin resistance (the driver of excess androgen production)
    • Lowers testosterone and DHEA-S levels
    • Restores regular menstrual cycles in 40-60% of PCOS patients who lose 10%+ of body weight
    • Improves response to fertility medications like clomiphene and letrozole

    Critical Safety Information

    • Stop GLP-1 before conception: Discontinue GLP-1 medication at least 2 months before attempting pregnancy (semaglutide has a 7-day half-life and should be fully cleared)
    • Use contraception: Fertility can improve rapidly on GLP-1, sometimes within months. If you are not planning pregnancy, use reliable contraception.
    • GLP-1 may reduce oral contraceptive effectiveness: Slowed gastric emptying can affect oral contraceptive absorption. Consider non-oral contraceptive methods.
    • Animal studies: GLP-1 medications showed adverse fetal effects in animal studies. Human data is insufficient.

    Plan Your Fertility Journey with Trimi

    If weight loss could improve your fertility, Trimi offers affordable GLP-1 therapy. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. Visit our treatment page to start.

    Frequently Asked Questions

    How quickly can fertility improve on GLP-1?

    Some women report restored ovulation within 2-3 months of starting GLP-1 medication, even with modest weight loss. This is why unplanned pregnancies on GLP-1 are common. If you are sexually active and not planning pregnancy, start contraception when you start GLP-1.

    Should I use GLP-1 as a fertility treatment?

    GLP-1 is not a fertility treatment per se, but pre-conception weight loss with GLP-1 can dramatically improve fertility outcomes. Some reproductive endocrinologists now recommend a period of GLP-1-assisted weight loss before fertility treatments for patients with obesity.

    Can men take GLP-1 to improve fertility?

    Yes, if they meet weight criteria. Male fertility improves with weight loss through better testosterone levels and sperm quality. There are no known direct negative effects of GLP-1 on male fertility, though you should discuss with your provider.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    What does the published clinical evidence show for GLP-1 medications and pregnancy and lactation?

    This is a safety-topic page; the relevant peer-reviewed sources are FDA prescribing information and pharmacovigilance literature cited below. For eligible patients, Trimi offers compounded semaglutide ($99/month annual plan) and compounded tirzepatide ($125/month annual plan), dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx) and reviewed by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Eligibility is determined by a licensed clinician. Results vary by individual; this is general information, not medical advice.

    Key Takeaways

    • Pregnancy and lactation: see cited FDA prescribing information and pharmacovigilance references for the contraindication / warning details. Discuss with your prescribing clinician.
    • Eligibility for GLP-1 treatment requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity. Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: December 25, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook
    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. U.S. Food and Drug Administration (2024). Wegovy (semaglutide) Prescribing Information — Pregnancy / Lactation Section. FDA.Read Study
    2. Cesta CE, Rotem R, Bateman BT, et al. (2024). Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy. JAMA Internal Medicine.Read StudyDOI: 10.1001/jamainternmed.2023.6663

    Was this article helpful?

    Keep Reading

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Learn the best techniques for taking GLP-1 weight loss progress photos. Consistent lighting, angles, and timing help you accurately track semaglutide and tirzepatide results.

    Start your GLP-1 journey — from $99/mo

    Get Started